# Owner-Directed Feline Aggression in Thailand: Characteristics, Associated Factors, and a Clinical Comparison of Treatments

**Authors:** Jarawee Supanta, Worakan Boonhoh, Orachun Hayakijkosol, Tuempong Wongtawan

PMC · DOI: 10.3390/life16020307 · Life · 2026-02-10

## TL;DR

This study explores owner-directed aggression in cats in Thailand and compares the effectiveness of CBD and fluoxetine in treating it.

## Contribution

The study introduces CBD as a viable alternative to fluoxetine for treating feline aggression without causing anorexia.

## Key findings

- CBD at 1 mg/kg/day was as effective as fluoxetine in reducing aggression without causing anorexia.
- Handling-induced aggression was universal, with grooming being the most common trigger.
- All treatment groups showed significant decreases in aggression scores compared to the control group.

## Abstract

Despite the global increase in cat ownership, some cats exhibit owner-directed aggression, resulting in caregiver injury, infection, and anxiety. Severe cases are commonly treated with selective serotonin reuptake inhibitors such as fluoxetine; however, adverse effects, particularly transient anorexia, often discourage treatment initiation. Cannabidiol (CBD), a natural compound with reported anxiolytic properties and minimal anorexic effects, may represent an alternative therapy. This study aimed to characterise owner-directed feline aggression in Thailand, identify associated factors, and compare the efficacy of CBD with fluoxetine. Most caregivers were females aged 20–40 years, and most cats were neutered mixed-breeds aged 1–6 years living indoors in multi-human and multi-cat households. For demographic variables, only human–cat interactions (e.g., petting) were significantly associated with aggression. Handling-induced aggression was universal, with grooming as the most common trigger (56%). In a single-blind, 4–8-week trial, 100 cats were randomly assigned to control, CBD 1 mg/kg/day, CBD 2 mg/kg/day, fluoxetine 0.5–1 mg/kg/day, or combined CBD and fluoxetine. Aggression scores decreased significantly in all treatment groups compared with control (p < 0.05), with no differences among active treatments. CBD at 1 mg/kg/day showed efficacy comparable to fluoxetine without anorexic effects.

## Linked entities

- **Chemicals:** fluoxetine (PubChem CID 3386), cannabidiol (PubChem CID 644019), CBD (PubChem CID 644019)

## Full-text entities

- **Diseases:** sleepiness (MESH:D000077260), vomiting (MESH:D014839), traffic accident (MESH:D000081084), diarrhoea (MESH:D003967), irritability (MESH:D001523), biting injuries (MESH:D001733), anorexia (MESH:D000855), anxiety (MESH:D001007), schizophrenia (MESH:D012559), injury (MESH:D014947), inflammatory (MESH:D007249), pain (MESH:D010146), scratch injuries (MESH:D002372), depression (MESH:D003866), zoonotic diseases (MESH:D015047), Aggression (MESH:D010554), increased appetite (MESH:D001068), cardiovascular diseases (MESH:D002318), infection (MESH:D007239), psychological (MESH:D000067073), toxicity (MESH:D064420), hyperandrogenism (MESH:D017588), ataxia (MESH:D001259), urinary retention (MESH:D016055)
- **Chemicals:** GABA (MESH:D005680), glutamate (MESH:D018698), diazepam (MESH:D003975), gabapentin (MESH:D000077206), serotonin (MESH:D012701), CBD (MESH:D002185), Fluoxetine (MESH:D005473), sertraline (MESH:D020280), oil (MESH:D009821), CBD oil (-)
- **Species:** Lyssavirus rabies (species) [taxon 11292], Sporothrix globosa (species) [taxon 545651], Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615], Xenopus laevis (African clawed frog, species) [taxon 8355], Rattus norvegicus (brown rat, species) [taxon 10116], Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606], Bartonella henselae (species) [taxon 38323]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942625/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942625/full.md

---
Source: https://tomesphere.com/paper/PMC12942625